Kannaway Makes Its Debut On European CBG Market
Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. (OTC:MJNA).
The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products.
Each bottle of Kannaway's newly released product contains 200 milligrams of CBD and 500 milligrams of CBG coming from European organic hemp.
Products are certified via the company's Triple Lab Testing process, the San Diego company confirmed.
"As CBD continues to grow in acceptance around the world, the market for cannabinoids like CBG also expands," noted Kannaway CEO Blake Schroeder. "Our company intends to continue to be at the forefront of expanding access to cannabinoids just as we have been with CBD."
Meantime, earlier this year, Kannaway tapped NHL and network marketing veteran Mike Hartman to its Sports Team to endorse CBD, and also Carolyn Dielmann Connolly as its new brand ambassador.
In January, Kannaway was named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list.
Courtesy image
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
